Daiichi’s EZH Contender Moves Ahead In Leukemia/Lymphoma

Pivotal Trial The First For A Dual Inhibitor

 
• By Ian Haydock
  
Leukemia
Novel Daiichi ATL Candidate Enters Pivotal Trial • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapy Areas